All filters
Slidesets
Exposure-Response Analysis of Lee 1810, a Lead Spectinamide Antibiotic in Mycobacterium tuberculosis Infected Mice- Santosh Wagh
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Improved efficacy of a cofactor-independent InhA inhibitor revealed by the C3HeB/ FeJ mouse model- Gregory Robertson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
High dose rifampicin for the treatment of TB meningitis: a dose finding study- Rob Aarnoutse, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Ototoxicity is associated with exposure to kanamycin and capreomycin in the treatment of multidrug-resistant tuberculosis- Mohammed Aslshaer
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
A Cardiac Risk Algorithm to Predict the Probability of Drug-Induced Torsades de Pointes with Novel Anti-TB Agents- Alexander Berg, PharmD, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Pharmacokinetics of rifampicin in African children - Evaluation of the new WHO dosing guidelines- Paolo Denti
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Prediction of increase in time-to-positivity after higher doses of rifampicin based on pharmacokinetic-pharmacodynamic modelling- Robin Svensson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Influence of Bacterial Growth Rate on Dose Optimization of Linezolid for Treatment of Tuberculosis- Kristina Bigelow
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017